4.7 Article

Personalized, Mechanically Strong, and Biodegradable Coronary Artery Stents via Melt Electrowriting

期刊

ACS MACRO LETTERS
卷 9, 期 12, 页码 1732-1739

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmacrolett.0c00644

关键词

-

资金

  1. University of Melbourne
  2. Australian Government Research Training Program Scholarship (Melbourne International Research Scholarship)
  3. Australian Research Council (ARC) [IC160100026]
  4. Queensland University of Technology's Institute of Heath and Biomedical Innovation (Innovation Ideas Grant)

向作者/读者索取更多资源

Biodegradable coronary artery stents are sought-after alternatives to permanent stents. These devices are designed to degrade after the blood vessel heals, leaving behind a regenerated artery. The original generation of clinically available biodegradable stents required significantly thicker struts (similar to 150 mu m) than nondegradable ones to ensure sufficient mechanical strength. However, these thicker struts proved to be a key contributor to the clinical failure of the stents. A current challenge lies in the fabrication of stents that possess both thin struts and adequate mechanical strength. In this contribution, we describe a method for the bottom-up, additive manufacturing of biodegradable composite stents with ultrathin fibers and superior mechanical properties compared to the base polymer. Specifically, we illustrate that melt electrowriting (MEW) can be used to 3D print composite structures with thin struts (60-80 mu m) and a high degree of geometric complexity required for stenting applications. Additionally, this technology allows additive manufacture of personalized stents that are customized to a patient's unique anatomy and disease state. Furthermore, we illustrate that polycaprolactone-reduced graphene oxide nanocomposites have superior mechanical properties compared to original polycaprolactone without detriment to the material's cytocompatibility and that customizable stent-like structures can be fabricated from these materials with struts as thin as 60 mu m, well below the target value for clinical use of 80 mu m.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据